Association between intravenous 5 % albumin administration and acute kidney injury after partial nephrectomy. A retrospective study

Document Type

Article

Publication Date

6-1-2025

Publication Title

Journal of clinical anesthesia

Abstract

BACKGROUND: Acute kidney injury (AKI) after partial nephrectomy is a frequent postoperative complication that can affect nearly half of patients, according to various studies. In the current study, we investigated the association of intraoperative administration of 5 % albumin, compared with crystalloids alone, with AKI after partial nephrectomy.

METHODS: This single-center retrospective study included adult patients undergoing partial nephrectomy. The primary endpoint was AKI within 72 h after surgery using the KIDGO definition. Secondary endpoints were time-to-AKI, reoperations, AKI severity and length of hospital stay. We used propensity score-based nearest-neighbor methods balance the patient baseline characteristics.

RESULTS: A total of 1688 patients were included in the analysis, with 809 receiving 5 % albumin and 879 in the control group. After matching, 729 patients received 5 % albumin, while 674 were controls. The incidence of acute kidney injury (AKI) was significantly higher in the 5 % albumin group (32.78 %) compared to the control group (25.51 %). Multivariate analysis revealed that receiving 5 % albumin was associated with a 32 % increased risk of developing AKI. Furthermore, the analysis indicated that this association was dose-dependent.

CONCLUSION: Our study suggests that intraoperative administration of 5 % albumin may not be a risk factor for AKI after partial nephrectomy. Given the discrepancy between these results and previous studies, a future prospective randomized controlled trial is needed to confirm our findings.

Medical Subject Headings

Humans; Acute Kidney Injury; Retrospective Studies; Male; Female; Middle Aged; Nephrectomy; Postoperative Complications; Aged; Risk Factors; Propensity Score; Intraoperative Care; Length of Stay; Incidence; Albumins; Adult; Crystalloid Solutions

PubMed ID

40373496

Volume

104

First Page

111873

Last Page

111873

Share

COinS